ASSTON PHARMACEUTICALS LIMITED

Recent announcements

• 7th Annual Report of Asston Pharmaceuticals Limited for the Financial Year 2025-26.7 Sep 2026 · Others / Reg. 34 (1) Annual Report
• Notice of 7th Annual General Meeting scheduled to be held on 29th September, 2026 at 12:30 P.M.7 Sep 2026 · AGM/EGM / AGM
• Allotment of 24,10,431 equity shares via Preferential Allotment5 Sep 2026 · Company Update / Allotment of Equity Shares
• Allotment of 24,10,431 equity shares via Preferential Allotment5 Sep 2026 · Others / Outcome without intimation
• Fixing Record date/Cut-off date to determine eligible shareholders for the E-voting facility for the 7th Annual General Meeting of the Company4 Sep 2026 · Corp. Action / Record Date
• Fixing 29th September, 2026, as the date for convening the 7th Annual General Meeting of the Company.4 Sep 2026 · AGM/EGM / AGM
• Meeting Update4 Sep 2026 · Company Update / Meeting Updates
• Change in Management4 Sep 2026 · Company Update / Change in Management
• Appointment of Statutory Auditor4 Sep 2026 · Company Update / Appointment of Statutory Auditor/s
• Outcome of the Board Meeting.4 Sep 2026 · Board Meeting / Outcome of Board Meeting
• The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakruti R Pali4 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
• The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakruti R Pali2 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
• The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakruti R Pali1 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
• The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakruti R Pali31 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
• Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 ,inter alia, to consider and approve 1. Appointment of M/s ....27 Aug 2026 · Board Meeting / Board Meeting
• Voting Result and Scrutinizer report for EGM held on 31st July, 2026 through VC-OAVM3 Aug 2026 · AGM/EGM / EGM
• Outcome and Proceedings of the 2nd Extraordinary General Meeting for F.Y. 2026-27, scheduled to be held on 31st July, 2026, at 12:30 P.M. through Video Conferencing and Other Audio-Visual Means.31 Jul 2026 · AGM/EGM / EGM
• Certificate under regulation 74(5) of SEBI (Depositories Participants) Regulation, 2018.14 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
• Newspaper Publication10 Jul 2026 · Company Update / Newspaper Publication
• Notice of Second Extraordinary General Meeting for F.Y. 2026-279 Jul 2026 · AGM/EGM / EGM
• Meeting Update2 Jul 2026 · Company Update / Meeting Updates
• Announcement regarding Extraordinary General Meeting of the Company.2 Jul 2026 · AGM/EGM / EGM
• Update on Board Meeting Scheduled to be held on 02nd July, 2026.2 Jul 2026 · Company Update / General
• Disclosure under regulation 30 (LODR)- Preferential Issue2 Jul 2026 · Company Update / Preferential Issue
• Outcome of the Board Meeting Scheduled to be held on 02nd July, 2026.2 Jul 2026 · Board Meeting / Outcome of Board Meeting
• Trading Window Closure24 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
• Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/07/2026 ,inter alia, to consider and approve proposal for raising ....24 Jun 2026 · Board Meeting / Board Meeting
• Audited Financial Results for the Financial Year ended 31st March, 202629 May 2026 · Result / Financial Results
• Audited Financial Results for the Financial Year ended 31st March, 202629 May 2026 · Result / Financial Results
• Outcome of Board Meeting scheduled to be held on 29th May, 202629 May 2026 · Board Meeting / Outcome of Board Meeting
• Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1. To consider and approve ....21 May 2026 · Board Meeting / Board Meeting
• <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....30 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
• Voting Result and Scrutinizer''s Report for EGM held on 28th April, 2026 through VC-OAVM28 Apr 2026 · AGM/EGM / EGM
• Outcome and Proceedings of the Extraordinary General Meeting held on 28th April, 2026, through (VC-OAVM).28 Apr 2026 · AGM/EGM / EGM
• Non-Applicability of Reg 24(A) of SEBI (LODR) Regulation, 2015 Annual Secretarial Compliance Report.21 Apr 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
• Certificate under regulation 74(5) of SEBI (Depositories Participants) Regulation 201814 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
• Intimation of record date i.e. 17th April, 2026, for the E-voting process pursuant to the Extraordinary General Meeting scheduled to be held on 28th April, 20266 Apr 2026 · Corp. Action / Record Date
• Please find attached the Notice of Extraordinary General Meeting scheduled to be held on 28th April, 20266 Apr 2026 · AGM/EGM / EGM
• Please find attached the outcome of the Board Meeting and the EGM date.30 Mar 2026 · AGM/EGM / EGM
• Details about the change in management.30 Mar 2026 · Company Update / Change in Management